---
figid: PMC6366304__JCO.2014.59.0018f2
figtitle: Common nodes of resistance to targeted therapies within the PI3K pathway
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC6366304
filename: JCO.2014.59.0018f2.jpg
figlink: /pmc/articles/PMC6366304/figure/F2/
number: F2
caption: Common nodes of resistance to targeted therapies within the PI3K pathway.
  PI3K pathway alterations that confer resistance to targeted therapies across various
  tumor types are shown. CRC, colorectal cancer; EGFR, epidermal growth factor receptor;
  HER2, human epidermal growth factor receptor 2; HR, hormone receptor; INPP4B, inositol
  polyphosphate 4-phosphatase type II; MET, hepatocyte growth factor receptor; mTORC,
  mammalian target of rapamycin complex; PDK1, phosphoinositide-dependent kinase 1;
  PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol 3-kinase catalytic
  subunit alpha; PIK3CG, phosphatidylinositol 3-kinase catalytic subunit gamma; PIK3R2,
  phosphatidylinositol 3-kinase regulatory subunit beta; PIP2, phosphatidylinositol
  4,5- bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
  and tensin homolog; RTK, receptor tyrosine kinase.
papertitle: Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.
reftext: Patricia Mucci LoRusso. J Clin Oncol. 2016 Nov 1;34(31):3803-3815.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8599766
figid_alias: PMC6366304__F2
figtype: Figure
redirect_from: /figures/PMC6366304__F2
ndex: 9f81e673-dea2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6366304__JCO.2014.59.0018f2.html
  '@type': Dataset
  description: Common nodes of resistance to targeted therapies within the PI3K pathway.
    PI3K pathway alterations that confer resistance to targeted therapies across various
    tumor types are shown. CRC, colorectal cancer; EGFR, epidermal growth factor receptor;
    HER2, human epidermal growth factor receptor 2; HR, hormone receptor; INPP4B,
    inositol polyphosphate 4-phosphatase type II; MET, hepatocyte growth factor receptor;
    mTORC, mammalian target of rapamycin complex; PDK1, phosphoinositide-dependent
    kinase 1; PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol 3-kinase
    catalytic subunit alpha; PIK3CG, phosphatidylinositol 3-kinase catalytic subunit
    gamma; PIK3R2, phosphatidylinositol 3-kinase regulatory subunit beta; PIP2, phosphatidylinositol
    4,5- bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
    and tensin homolog; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R2
  - BRAF
  - EGFR
  - PIK3CA
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PDK1
  - PDPK1
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - INPP4B
  - MTOR
  - RPTOR
  - Tie
  - Ras85D
  - InR
  - Egfr
  - Dsor1
  - Mtk
  - ras
  - Ras64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Myb
  - Taf5
  - l(1)G0020
  - Taf4
  - Rpn2
  - Sap-r
  - Pdk1
  - mid
  - Pten
  - Akt
  - crc
  - cr-c
  - Calr
  - Crtc
  - pik3r2
  - braf
  - si:dkey-222f8.3
  - egfra
  - pik3ca
  - rab1ab
  - ddx3xb
  - pdk1
  - ptenb
  - inpp4b
  - akt1
  - kras
  - estrogen
  - Cancer
  - Lung cancer
---
